Credit Suisse’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $250K | Sell |
|
|||||
|
2023
Q2 | $466K | Buy |
|
|||||
|
2023
Q1 | $335K | Buy |
|
|||||
|
2022
Q4 | $365K | Sell |
|
|||||
|
2022
Q3 | $566K | Buy |
|
|||||
|
2022
Q2 | $621K | Sell |
|
|||||
|
2022
Q1 | $684K | Sell |
|
|||||
|
2021
Q4 | $964K | Buy |
|
|||||
|
2021
Q3 | $1.05M | Buy |
|
|||||
|
2021
Q2 | $1.3M | Sell |
|
|||||
|
2021
Q1 | $1M | Sell |
|
|||||
|
2020
Q4 | $1.16M | Sell |
|
|||||
|
2020
Q3 | $1.03M | Sell |
|
|||||
|
2020
Q2 | $1.32M | Buy |
|
|||||
|
2020
Q1 | $393K | Sell |
|
|||||
|
2019
Q4 | $770K | Buy |
|
|||||
|
2019
Q3 | $504K | Sell |
|
|||||
|
2019
Q2 | $678K | Sell |
|
|||||
|
2019
Q1 | $1.31M | Buy |
|
|||||
|
2018
Q4 | $1.1M | Buy |
|
|||||
|
2018
Q3 | $680K | Sell |
|
|||||
|
2018
Q2 | $1.2M | Buy |
|
|||||
|
2018
Q1 | $788K | Buy |
|
|||||
|
2017
Q4 | $628K | Sell |
|
|||||
|
2017
Q3 | $961K | Buy |
|
|||||
|
2017
Q2 | $729K | Sell |
|
|||||
|
2017
Q1 | $2.99M | Buy |
|
|||||
|
2016
Q4 | $2.98M | Sell |
|
|||||
|
2016
Q3 | $3.31M | Buy |
|
|||||
|
2016
Q2 | $1.17M | Buy |
|
|||||
|
2016
Q1 | $703K | Buy |
|
|||||
|
2015
Q4 | $359K | Buy |
|
|||||
|
2015
Q3 | $330K | Sell |
|
|||||
|
2015
Q2 | $2.53M | Buy |
|
|||||
|
2015
Q1 | $771K | Buy |
|
|||||
|
2014
Q4 | $1.13M | Buy |
|
|||||
|
2014
Q3 | $327K | Buy |
|
|||||
|
2014
Q2 | $376K | Sell |
|
|||||
|
2014
Q1 | $1.33M | Buy |
|
|||||
|
2013
Q4 | $504K | Buy |
|
|||||
|
2013
Q3 | $324K | Sell |
|
|||||
|
2013
Q2 | $250K | Buy |
|